ClariVest Asset Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

ClariVest Asset Management’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-36,348	Closed	-$1.06M	–	793
2021 Q4	$1.06M	Sell	36,348 -47,365	-57%	-$1.36M	0.03%	308
2021 Q3	$1.81M	Sell	83,713 -1,882	-2%	-$45.4K	0.06%	245
2021 Q2	$2.2M	Sell	85,595 -26,409	-24%	-$564K	0.07%	211
2021 Q1	$2.04M	Buy	112,004 +1,400	+1%	+$23.3K	0.07%	206
2020 Q4	$1.28M	Sell	110,604 -58,459	-35%	-$534K	0.04%	249
2020 Q3	$1.29M	Sell	169,063 -37,674	-18%	-$285K	0.04%	277
2020 Q2	$1.36M	Sell	206,737 -23,371	-10%	-$130K	0.04%	280
2020 Q1	$1.18M	Buy	230,108 +75,828	+49%	+$459K	0.04%	272
2019 Q4	$1.18M	Buy	+154,280	New	+$900K	0.03%	331

Other funds holding CDMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

ClariVest Asset Management's CDMO Position: Q1 2022 in Review

ClariVest Asset Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2022, closing a stake of 36,348 shares — an estimated $1.06M sold.

ClariVest Asset Management first reported a position in CDMO in Q4 2019 and held it in 9 quarters. The position peaked at $2.2M in Q2 2021. 193 funds tracked by Wall St. Rank hold CDMO as of Q1 2022.

ClariVest Asset Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
ClariVest Asset Management sold 36,348 Avid Bioservices, Inc. Common Stock shares in Q1 2022, an estimated $1.06M.
ClariVest Asset Management first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2019 and held it in 9 quarters.
ClariVest Asset Management's Avid Bioservices, Inc. Common Stock position peaked at $2.2M in Q2 2021.
193 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2022.

Based on ClariVest Asset Management's 13F filing for Q1 2022, filed 4 May 2022.